OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transcriptional Biomarkers of Differentially Detectable Mycobacterium tuberculosis in Patient Sputum
Kayvan Zainabadi, Kohta Saito, Saurabh Mishra, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 6
Kayvan Zainabadi, Kohta Saito, Saurabh Mishra, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 6
Showing 6 citing articles:
The performance of tongue swabs for detection of pulmonary tuberculosis
Christopher Ealand, Astika Sewcharran, Julian S. Peters, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Christopher Ealand, Astika Sewcharran, Julian S. Peters, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
Nitric oxide induces the distinct invisibility phenotype of Mycobacterium tuberculosis
Brindha Gap-Gaupool, Sarah Glenn, Emily Milburn, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Brindha Gap-Gaupool, Sarah Glenn, Emily Milburn, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
(2023)
Open Access | Times Cited: 2
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
(2023)
Open Access | Times Cited: 2
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 2
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 2
A bedaquiline, pyrazinamide, levofloxacin, linezolid, clofazimine second line regimen for tuberculosis displays similar early bactericidal activity as the standard rifampin based first line regimen
Kayvan Zainabadi, Stalz Charles Vilbrun, L Mathurin, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 2, pp. e447-e456
Open Access | Times Cited: 1
Kayvan Zainabadi, Stalz Charles Vilbrun, L Mathurin, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 2, pp. e447-e456
Open Access | Times Cited: 1
Exposure to nitric oxide drives transition to differential culturability inMycobacterium tuberculosis
Sarah Glenn, Brindha Gap-Gaupool, Emily Milburn, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Sarah Glenn, Brindha Gap-Gaupool, Emily Milburn, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
